RFK Jr.'s committee approves manufacture of peptides without safety data

A committee selected by RFK Jr. has approved the manufacturing of peptides that he personally uses, despite the absence of human safety and efficacy data. The approval highlights concerns about regulatory oversight and potential conflicts of interest in the decision-making process.